Boothbay Fund Management’s Translational Development Acquisition Corp TDAC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDAC
Boothbay Fund Management's TDAC Position: Q3 2026 in Review
Boothbay Fund Management sold out of Translational Development Acquisition Corp (TDAC) in Q3 2026, closing a stake of 232,034 shares — an estimated $2.48M sold.
Boothbay Fund Management first reported a position in TDAC in Q2 2026 and held it in 1 quarter. The position peaked at $2.48M in Q2 2026. 37 funds tracked by Wall St. Rank hold TDAC as of Q3 2026.
- Boothbay Fund Management reported no remaining Translational Development Acquisition Corp position as of Q3 2026 after selling out during the quarter.
- Boothbay Fund Management sold 232,034 Translational Development Acquisition Corp shares in Q3 2026, an estimated $2.48M.
- Boothbay Fund Management first reported a position in Translational Development Acquisition Corp in Q2 2026 and held it in 1 quarter.
- Boothbay Fund Management's Translational Development Acquisition Corp position peaked at $2.48M in Q2 2026.
- 37 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q3 2026.
Based on Boothbay Fund Management's 13F filing for Q3 2026, filed 16 Nov 2026.